Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04868994

Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis

Contribution of Whole Body Muscle MRI for Early Diagnosis of Amyotrophic Lateral Sclerosis.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Nearly 60% of Amyotrophic Lateral Sclerosis (ALS) patients have a low level of diagnostic certainty (possible, probable) at the time of diagnosis. In the absence of biomarkers, this diagnosis is based, among other things, on the demonstration of the diffusion of signs of denervation by electroneuromyography (ENMG). The objective of this study is to improve the earliness and the level of diagnostic certainty by better demonstrating the diffusion of the denervation process by whole body muscular MRI.

Detailed description

The objective of this study is to show that the combination of ENMG and whole body muscle MRI (WB-MRI) can increase the diagnosis of definite ALS at the onset of the disease For 50 consecutive patients with suspected ALS, the present study will prospectively perform needle electromyography (EMG) and muscle analyses on whole body MRI. The diagnostic category will be determined by revised El Escorial criteria and Awaji criteria. On whole body MRI acquisition, for 83 muscles, will be explored fatty infiltration and atrophy on fat images (chronic denervation) and muscle edema on water images (acute denervation). EMG studies will be performed in at least 10 muscles (tongue, biceps brachii, first dorsalis interosseous, T10 paraspinalis, vastus lateralis, and tibialis anterior). Diagnostic classification according EMG and/ or MRI abnormalities in bulbar and the 3 spinal regions will be compared independently.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTWhole Body MRI and ENMGWhole body muscle MRI lasting 30 to 45 min without injection of contrast medium an ENMG

Timeline

Start date
2021-06-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2021-05-03
Last updated
2024-08-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04868994. Inclusion in this directory is not an endorsement.

Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis (NCT04868994) · Clinical Trials Directory